Wave Life Sciences
(NASDAQ) WVE
Wave Life Sciences Financials at a Glance
Market Cap
$1.20BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$71.80M
Net Income (TTM)
-$183.59M
EPS (TTM)
-$1.05
P/E Ratio
-5.93
Dividend
$0.00
Beta (Volatility)
1.49 (Average)
Dividend
$0.00
Beta (Volatility)
1.49 (Average)
Price
$6.20
Volume
3,550,097.501
Open
$6.36
Price
$6.20
Volume
3,550,097.501
Open
$6.36
Previous Close
$6.25
Daily Range
$5.76 - $6.36
52-Week Range
$5.02 - $21.73
Estimated Earnings Date
Jul 30, 2026
Dividend
$0.00
Beta (Volatility)
1.49 (Average)
Price
$6.20
Volume
3,550,097.501
Open
$6.36
Previous Close
$6.25
Daily Range
$5.76 - $6.36
52-Week Range
$5.02 - $21.73
Estimated Earnings Date
Jul 30, 2026
WVE News
WVE: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Wave Life Sciences
Industry
Pharmaceuticals
Sector
Health CareEmployees
317
CEO
Paul B. Bolno, MD, MBA
Website
www.wavelifesciences.comHeadquarters
Singapore, CE 018936, SG
WVE Financials
Key Financial Metrics (TTM)
Gross Margin
93.79%
Operating Margin
-274.21%
Net Income Margin
-255.70%
Return on Equity
-56.41%
Return on Capital
-39.59%
Return on Assets
-31.46%
Earnings Yield
-16.86%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.20BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
192.40M
Volume
3.55M
Avg. Volume
3.82M
Financials (TTM)
Gross Profit
$67.34M
Operating Income
-$196.88M
EBITDA
-$174.59M
Operating Cash Flow
-$182.35M
Capital Expenditure
-$981.99K
Free Cash Flow
-$183.34M
Cash & ST Invst.
$544.59M
Total Debt
$15.72M
Wave Life Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$38.25M
+316.9%
Gross Profit
$38.25M
+445.5%
Gross Margin
100.00%
N/A
Market Cap
$1.20BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$3.79M
N/A
Employees
317
N/A
Net Income
-$26.09M
+44.4%
EBITDA
-$23.78M
+46.8%
Quarterly Fundamentals
Total Cash
$544.59M
+124.0%
Total Debt
$15.72M
-33.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$7.39M
-53.0%
Short Term Debt
$8.33M
+5.6%
Return on Assets
-31.46%
N/A
Return on Invested Capital
-36.89%
N/A
Free Cash Flow
-$59.99M
+5.1%
Operating Cash Flow
-$59.55M
+5.5%